title: Budget Impact Analysis Of Wider Adoption Of Biphasic Insulin Aspart (Biasp) In The Treatment Of Type 2 Diabetes Mellitus (T2dm): A Perspective Of Patients Treated By Public Providers In Singapore.
authors.affiliation: IMS Asia Pacific, Singapore.
authors.forename: S C
authors.initials: SC
authors.lastname: Tan
authors.affiliation: Novo Nordisk Pharma Malaysia, Kuala Lumpur, Malaysia.
authors.forename: P
authors.initials: P
authors.lastname: Matzen
authors.affiliation: Novo Nordisk Pharma Singapore, Singapore.
authors.forename: S P
authors.initials: SP
authors.lastname: Khoo